- Published at
- by manilatimes.net
mixed
mixed
News for Oncotelic Therapeutics, Inc. (MATN)
- Published at
- by gurufocus.com
mixedmixedOncotelic Accesses Rapid IND Development Platform through Partnership with Medicilon
AGOURA HILLS, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTLC). Oncotelic Therapeutics Inc., a leader in RNA-based therapeutics,- Published at
- by gurufocus.com
neutralneutralOncotelic CEO Vuong Trieu to Present Groundbreaking Research on Transforming Growth Factor Beta 2 (TGFB2) at SWCR 2025 Conference
AGOURA HILLS, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTLC). Oncotelic Therapeutics, a leader in RNA-based therapeutics, is ple- Published at
- by manilatimes.net
neutralneutral- Published at
- by investing.com
positivepositiveOncotelic therapeutics CEO Trieu Vuong acquires $8,626 in stock By Investing.com
Oncotelic therapeutics CEO Trieu Vuong acquires $8,626 in stock- Published at
- by globenewswire.com
positivepositiveONCOTELIC CLINICAL PRESENTATIONS AT SITC 2024
AGOURA HILLS, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its presentation at SITC 2024. Dr....- Published at
- by investing.com
mixedmixedONCOTELIC PRESENTATION AT PRECISION IN DRUG DISCOVERY & PRECLINICAL SUMMIT SAN DIEGO 2024 By Investing.com
ONCOTELIC PRESENTATION AT PRECISION IN DRUG DISCOVERY & PRECLINICAL SUMMIT SAN DIEGO 2024- Published at
- by investing.com
positivepositiveOncotelic Therapeutics CEO buys $10,000 in company stock By Investing.com
Oncotelic Therapeutics CEO buys $10,000 in company stock- Published at
- by globenewswire.com
mixedmixedProduct Manager Scott Myers to Present at 2nd Global Summit on Artificial Intelligence
AGOURA HILLS, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) (- Published at
- by globenewswire.com
neutralneutralONCOTELIC TO PRESENT AT THE 20TH ANNUAL CONGRESS OF INTERNATIONAL DRUG DISCOVERY SCIENCE & TECHNOLOGY
AGOURA HILLS, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will speak at...- Published at
- by globenewswire.com
neutralneutralONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETING
AGOURA HILLS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will be...- Published at
- by globenewswire.com
neutralneutralONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING
AGOURA HILLS, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its Chief Clinical Officer- Dr. Anthony...- Published at
- by investing.com
neutralneutralMosaic to acquire Oncotelic's cancer therapies By Investing.com
Mosaic to acquire Oncotelic's cancer therapies- Published at
- by globenewswire.com
negativenegativeOncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.
AGOURA HILLS, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (- Published at
- by globenewswire.com
mixedmixedOncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023
AGOURA HILLS, Calif., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced...